跳至主要内容
临床试验/NCT00742235
NCT00742235已完成不适用

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2007年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
99
试验地点
1
主要终点
Baseline 25-OH Vitamin D Level

研究概览

简要总结

Vitamin D deficiency (low levels of vitamin D in the blood) is a common problem. A recently discovered protein, called hCAP18, likely plays an important role in the immune system and may depend on adequate levels of vitamin D. It is not known what levels of vitamin D are needed to allow the body to make this protein. Nor is it known if giving vitamin D to people who are found to be deficient will help boost levels of hCAP18. This study aims to clarify the relationship between vitamin D levels and hCAP18.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80

排除标准

  • Known active infectious disease or chronic inflammatory disorder
  • Hypercalcemia
  • Chronic kidney disease
  • Pregnancy

研究组 & 干预措施

1

Experimental

Vitamin D insufficient (treated with ergocalciferol 50,000 IU every other day x 5 doses)

干预措施: ergocalciferol (Drug)

结局指标

主要结局

Baseline 25-OH Vitamin D Level

时间窗: Baseline

hCAP18 Levels

时间窗: Baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ishir Bhan, MD, MPH

Instructor in Medicine

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验